These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21685875)

  • 1. Molecular basis of positive allosteric modulation of GluN2B NMDA receptors by polyamines.
    Mony L; Zhu S; Carvalho S; Paoletti P
    EMBO J; 2011 Jun; 30(15):3134-46. PubMed ID: 21685875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insights into gating mechanism and allosteric regulation of NMDA receptors.
    Wu E; Zhang J; Zhang J; Zhu S
    Curr Opin Neurobiol; 2023 Dec; 83():102806. PubMed ID: 37950957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GluN2B subunit selective N-methyl-D-aspartate receptor ligands: Democratizing recent progress to assist the development of novel neurotherapeutics.
    Ugale V; Deshmukh R; Lokwani D; Narayana Reddy P; Khadse S; Chaudhari P; Kulkarni PP
    Mol Divers; 2024 Jun; 28(3):1765-1792. PubMed ID: 37266849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unveiling the molecular basis of lobeline's allosteric regulation of NMDAR: insights from molecular modeling.
    Remya C; Variyar EJ; Omkumar RV; Sadasivan C; Dileep KV
    Sci Rep; 2023 Dec; 13(1):22418. PubMed ID: 38104236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel positive allosteric modulators targeting GluN1/2A NMDARs as anti-stroke therapeutic agents.
    Zhu H; Chen X; Zhang L; Liu X; Chen J; Zhang HT; Dong M
    RSC Med Chem; 2024 Apr; 15(4):1307-1319. PubMed ID: 38665828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric signaling and dynamics of the clamshell-like NMDA receptor GluN1 N-terminal domain.
    Zhu S; Stroebel D; Yao CA; Taly A; Paoletti P
    Nat Struct Mol Biol; 2013 Apr; 20(4):477-85. PubMed ID: 23454977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design.
    Volgraf M; Sellers BD; Jiang Y; Wu G; Ly CQ; Villemure E; Pastor RM; Yuen PW; Lu A; Luo X; Liu M; Zhang S; Sun L; Fu Y; Lupardus PJ; Wallweber HJ; Liederer BM; Deshmukh G; Plise E; Tay S; Reynen P; Herrington J; Gustafson A; Liu Y; Dirksen A; Dietz MG; Liu Y; Wang TM; Hanson JE; Hackos D; Scearce-Levie K; Schwarz JB
    J Med Chem; 2016 Mar; 59(6):2760-79. PubMed ID: 26919761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of triheteromeric N-Methyl-D-Aspartate Receptors.
    Cheriyan J; Balsara RD; Hansen KB; Castellino FJ
    Neurosci Lett; 2016 Mar; 617():240-6. PubMed ID: 26917100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists.
    Stroebel D; Buhl DL; Knafels JD; Chanda PK; Green M; Sciabola S; Mony L; Paoletti P; Pandit J
    Mol Pharmacol; 2016 May; 89(5):541-51. PubMed ID: 26912815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function.
    Hackos DH; Lupardus PJ; Grand T; Chen Y; Wang TM; Reynen P; Gustafson A; Wallweber HJ; Volgraf M; Sellers BD; Schwarz JB; Paoletti P; Sheng M; Zhou Q; Hanson JE
    Neuron; 2016 Mar; 89(5):983-99. PubMed ID: 26875626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMDA receptor structures reveal subunit arrangement and pore architecture.
    Lee CH; Lü W; Michel JC; Goehring A; Du J; Song X; Gouaux E
    Nature; 2014 Jul; 511(7508):191-7. PubMed ID: 25008524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of a heterotetrameric NMDA receptor ion channel.
    Karakas E; Furukawa H
    Science; 2014 May; 344(6187):992-7. PubMed ID: 24876489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease.
    Paoletti P; Bellone C; Zhou Q
    Nat Rev Neurosci; 2013 Jun; 14(6):383-400. PubMed ID: 23686171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtype-dependent N-methyl-D-aspartate receptor amino-terminal domain conformations and modulation by spermine.
    Sirrieh RE; MacLean DM; Jayaraman V
    J Biol Chem; 2015 May; 290(20):12812-20. PubMed ID: 25829490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rescuing tri-heteromeric NMDA receptor function: the potential of pregnenolone-sulfate in loss-of-function GRIN2B variants.
    Kellner S; Berlin S
    Cell Mol Life Sci; 2024 May; 81(1):235. PubMed ID: 38795169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GluN2A and GluN2B N-Methyl-D-Aspartate Receptor (NMDARs) Subunits: Their Roles and Therapeutic Antagonists in Neurological Diseases.
    Ladagu AD; Olopade FE; Adejare A; Olopade JO
    Pharmaceuticals (Basel); 2023 Oct; 16(11):. PubMed ID: 38004401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downstream Allosteric Modulation of NMDA Receptors by 3-Benzazepine Derivatives.
    Ritter N; Disse P; Aymanns I; Mücher L; Schreiber JA; Brenker C; Strünker T; Schepmann D; Budde T; Strutz-Seebohm N; Ametamey SM; Wünsch B; Seebohm G
    Mol Neurobiol; 2023 Dec; 60(12):7238-7252. PubMed ID: 37542648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights into NMDA receptor pharmacology.
    Zhou C; Tajima N
    Biochem Soc Trans; 2023 Aug; 51(4):1713-1731. PubMed ID: 37431773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular targets of spermidine: implications for cancer suppression.
    Zimmermann A; Hofer SJ; Madeo F
    Cell Stress; 2023 Jul; 7(7):50-58. PubMed ID: 37431488
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.